Latest Breaking News On - University of pennsylvania gene therapy program - Page 4 : comparemela.com

Passage Bio Reports Second Quarter 2023 Financial Results and Provides Recent Business Highlights

Reported promising interim data from Cohorts 1-4 in the Imagine-1 clinical trial for GM1 gangliosidosis ; PBGM01 continued to have a favorable safety profile and dose-dependent effects on key CSF.

United statesUniversity of pennsylvaniaDolan sondhiWilliam chouMike beyerStuart hendersonCorporate governance committeePassage bio incDevelopment rd expensesExchange commissionProfessor of researchUniversity of pennsylvania gene therapy programSam brown incHealthcare communicationsGenetic medicineWeill cornell medicine

Passage Bio Announces Promising Interim Clinical Data from First Eight Patients with GM1 Gangliosidosis in Imagine-1 Study

Interim safety data up to 28 months showed Dose 1 and 2 of PBGM01 were well tolerated and had a favorable safety and immunological profileDose 2 resulted in substantial improvements in key CSF.

United statesUniversity of pennsylvaniaStuart hendersonMike beyerWilliam chouPassage bio incUniversity of pennsylvania gene therapy programExchange commissionSam brown incDrug administrationEuropean commissionHealthcare communicationsHistory studyPassage bioOrphan drugRare pediatric disease

Passage Bio Welcomes Dolan Sondhi, Ph D to Board Of Directors - Passage Bio (NASDAQ:PASG)

PHILADELPHIA, July 31, 2023 (GLOBE NEWSWIRE) Passage Bio, Inc. (NASDAQ:PASG), a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system (CNS)

University of pennsylvaniaUnited statesTom woiwodeStuart hendersonDolan sondhiThomas woiwodeWilliam chouMike beyerProfessor of researchStephens collegeDelhi universityPassage bio incHealthcare communicationsBrown universityUniversity of pennsylvania gene therapy programSam brown inc

Passage Bio to Present at Goldman Sachs 44th Annual Global Healthcare Conference

Passage Bio to Present at Goldman Sachs 44th Annual Global Healthcare Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

University of pennsylvaniaUnited statesStuart hendersonpassage bioWilliam chouPassage bio incMike beyersam brown incUniversity of pennsylvania gene therapy programHealthcare communicationsGoldman sachsAnnual global healthcare conferenceDana pointPassage bioGene therapy programBio investorsBio mediaMike beyersam brown

Precision BioSciences Reports First Quarter 2023 Financial Results and Provides Business Update

- Program Updates Planned for Azer-cel and PBCAR19B in May 2023 - Presented data on PBGENE-HBV program at Global Hepatitis Summit 2023; PBGENE-DMD program data update upcoming at ASGCT. | May 9, 2023

United statesMichael amorosoEli lillyLos angelesTrademark officeAmerican society of gene cell therapy meetingNovartis partnered programPrecision biosciences incCompany lillyUniversity of pennsylvania gene therapy programAmerican society of gene cell therapyDevelopment expensesPrecision biosciencesChief executive officerGlobal hepatitis summitAmerican society